Live AusBiotech updates | Page 4

Live AusBiotech news coverage of developments with the latest updates. Stay on top of latest AusBiotech news stories and find out what just happened, what is going on with AusBiotech. The latest real-time news updates and headlines on AusBiotech
BioCurate, Takeda Renew Pact to Speed Up Discoveries
AusBiotech announces CEO departure
Moderna Hits Midpoint in mRNA Factory Construction
Optiscan Imaging Ties with Histology in Breast Cancer Study
Australian-developed drug receives US FDA approval
Adapt Ideations Names New Chief Operating Officer
Early Oesophageal Cancer Diagnosis Now Closer for At-Risk
BCAL Diagnostics Secures Vital Breast Cancer Signature
Feedback sought on Employee Share Schemes policy
Imugene Wins Japanese Patent for PD1-Vaxx Drug Candidate
Actinogen Medical closes $10 million rights issue offer
First Paediatric Brain Cancer Patient Treated in FivepHusion Trial
Save $350 with AusBiotech 2023 early-bird rates
Emyria Raises Capital to Advance Mental Health Programs
Non-animal models could deliver $1.5B growth
Pharmaxis Reveals Positive Preclinical Results for PXS-5505
Recognition for Vetter in annual Frost & Sullivan awards
ENA Respiratory Bolsters Leadership, Secures Extended DoD Funding
MRFF's Clinical Trials Activity Initiative Evaluated
Botanix Pharmaceuticals Promotes COO to CEO Position
Clarity Begins High-Dose Prostate Cancer Trial Treatment
Feedback sought on FMT exemption and draft guidance
Opthea Raises $80M in Fully Underwritten Placement, Offer
Telix Result Indicates Sustainable Commercial-Stage Transition
Vaxxas Secures Wellcome Grant for Needle-Free Typhoid Patch Study
Nominations open for AusBiotech Board 22 August
Biotron Concludes BIT225 Covid Clinical Trial Phase
CUREator+ Funds Commercial BioMedTech Startups
Imugene Acquires License for Allogeneic CAR-T, Eyes 2024 Study
AusBiotech 2023 programme launched
Chimeric Reveals Encouraging In-Vitro Data for CHM 0301 Platform
Moderna Expands Presence in Australia on Major Day
CSL Sees Record Plasma Collections, Boosts Profit Growth
AusBiotech 2023 Millis Orator announced
Notification of AGM 2023 and forthcoming elections
Clarity's Prostate Cancer Trial Progresses to Top Dose Level
Merck partners to pilot first DeadlyLabs kit
Aus Vaccine Breakthrough Targets EBV-Linked Cancers, MS
AusBiotech Unveils First-Ever ESG Guide for Biotech SMEs
AusBiotech Discusses Industry Growth Program Consultation
Dimerix Completes Second DSMB Review of ACTION3 Trial Successfully
Peter Mac Introduces BindiMaps, Victoria's First Indoor Hospital Navigator
Immutep Gets Positive Feedback from European Medicines Agency
US Investment in Australian Biotechs Soars: AusBiotech Report
Allarity, FivepHusion Partner to Develop Deflexifol, DRP Diagnostics
AusBiotech responds to research funds consultation
HaemaLogiX, Peter Mac Ink CAR-T Clinical Trial Deal
Japan Grants Chimeric Patent Allowance for Chlorotoxin